Investing.com - Financial Markets Worldwide

Zhejiang Shenghua Biok Biology Co Ltd (600226)

Shanghai
Currency in CNY
2.76
+0.01(+0.36%)
Closed·

600226 Financial Summary

Key Ratios

P/E Ratio47.74
Price/Book2.46
Debt / Equity21.31%
Return on Equity5.12%
Dividend Yield0.00%
EBITDA67.70M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa35.55106.0679.44130.07149.68
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-570.25-27-51.7711.78-15.31
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-942.26375.03482.47165.76189.45
Balance Sheet
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa3,050.412,944.83,606.934,314.624,495.82
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa390.72221.99242.82453.49601.16
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa-782.25-407.13171.63473.76433.84
Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa263.89605.3-92.46-440.9-187.8
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa46.54105.2718.52-76.7-31.31
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa87.78730.85293.28-511.89-93.74
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-147.68-543.62215.85431.1538.15
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-13.09292525.04-157.41-85.88
* In Millions of CNY (except for per share items)

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.00

Earnings

Latest Release
Apr 21, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Zhejiang Shenghua Biok's earnings for the latest quarter?

The Zhejiang Shenghua Biok EPS (TTM) is 0.06. Zhejiang Shenghua Biok reported sales of 382.34, net income of 70.10, and EPS of 0.02 for the latest quarter.

What was Zhejiang Shenghua Biok's net income for the latest quarter?

Zhejiang Shenghua Biok's net income for the latest quarter was 70.10.

How did Zhejiang Shenghua Biok's performance compare year-over-year in the latest quarter?

The company's revenue moved from 426.41 in the previous quarter to 382.34 in the latest quarter, and net income moved from 2.07 to 70.10 compared to the previous quarter.

What is Zhejiang Shenghua Biok's net profit margin on a TTM basis?

Zhejiang Shenghua Biok's trailing twelve months (TTM) net profit margin is 14.20%.

How does Zhejiang Shenghua Biok's debt to equity ratio compare to industry standards?

Zhejiang Shenghua Biok's total debt-to-equity ratio is 21.31%.

What is Zhejiang Shenghua Biok's return on investment on a TTM basis?

Zhejiang Shenghua Biok's trailing twelve months (TTM) return on investment (ROI) is 5.12%.

Did Zhejiang Shenghua Biok gain or lose cash last quarter?

In the latest quarter, Zhejiang Shenghua Biok's net change in cash was 64.47 million.

What were Zhejiang Shenghua Biok's total assets and liabilities in the latest quarter?

As of the latest quarter, Zhejiang Shenghua Biok reported total assets of 4,657.31 million and total liabilities of 530.67 million.

How has Zhejiang Shenghua Biok's total revenue grown this year?

Zhejiang Shenghua Biok's total revenue was 426.41 in the previous quarter and 382.34 in the latest quarter.

What is Zhejiang Shenghua Biok's gross margin on a TTM basis?

Zhejiang Shenghua Biok's trailing twelve months (TTM) gross margin is 8.62%.

What was Zhejiang Shenghua Biok's revenue per share for the latest quarter?

Zhejiang Shenghua Biok's revenue per share for the latest quarter was 3.95.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.